NCT02614625

Brief Summary

An increasing number of clinical studies on SD-OCT of ocular pathologies and potential new clinical applications has recently been published in the peer-reviewed literature. However, the successful use of SD-OCT in routine clinical use depends upon the diagnostic sensitivity, biometric accuracy and reliability of the SD-OCT machines. This prospective, comparative, observational study aims to evaluate the imaging quality and diagnostic performance of two commercially available SD-OCT machines for both the anterior and posterior segment of the eye.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Dec 2014

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2014

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

October 12, 2015

Completed
1 month until next milestone

First Posted

Study publicly available on registry

November 25, 2015

Completed
6 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2015

Completed
Last Updated

November 25, 2015

Status Verified

November 1, 2015

Enrollment Period

1 year

First QC Date

October 12, 2015

Last Update Submit

November 22, 2015

Conditions

Outcome Measures

Primary Outcomes (1)

  • Sensitivity as the proportion of anatomical structures that are detectable with the two instruments

    Anatomical structures include e.g. sublayers of the cornea, sublayers of the retina, retinal vessels etc.

    6 months

Secondary Outcomes (2)

  • Corneal sublayer thickness (µm) and retinal sublayer thickness (µm) obtained with the two study instruments

    6 months

  • Corneal sublayer thickness and retinal sublayer thickness obtained with the two study instruments

    6 months

Study Arms (4)

Normal subjects

Patient with healthy, normal eyes

Eyes with corneal disease

Subjects that have any of the following conditions * Corneal dystrophy or degeneration * Corneal scarring * Corneal ulcer * Corneal injury * Keratoconus * Patients who had undergone corneal surgery * Patients with other corneal disease

Eyes with retinal disease

Subjects that have any of the following conditions: * Diabetic macular edema * Cystoid macular edema * Age related macular degeneration * Retinal vascular disorders (e.g. retinal artery occlusion) * Epiretinal membrane * Choroidal nevus * Macular hole * Patients who had undergone retinal surgery * Patients with other retinal disease

Eyes with glaucoma

Eyes diagnosed with glaucoma of any type and any stage

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

200 eyes of 100 patients will be included.

You may qualify if:

  • Age 21 and older
  • Normal eyes or
  • Eyes with corneal disease:
  • Subjects that have any of the following conditions
  • Corneal dystrophy or degeneration
  • Corneal scarring
  • Corneal ulcer
  • Corneal injury
  • Keratoconus
  • Patients who had undergone corneal surgery
  • Patients with other corneal disease or - Eyes with retinal disease:
  • Subjects that have any of the following conditions:
  • Diabetic macular edema
  • Cystoid macular edema
  • Age related macular degeneration
  • +10 more criteria

You may not qualify if:

  • Any of the following will exclude a subject from the study:
  • Patients who are not able to cooperate or with insufficient ability to fixate (tremor, nystagmus)
  • Pregnancy (pregnancy test will be taken in women of reproductive age before enrolment into the trial)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

AKh Linz

Linz, Upper Austria, 4021, Austria

RECRUITING

Related Publications (1)

  • Luft N, Ring MH, Dirisamer M, Mursch-Edlmayr AS, Kreutzer TC, Pretzl J, Bolz M, Priglinger SG. Corneal Epithelial Remodeling Induced by Small Incision Lenticule Extraction (SMILE). Invest Ophthalmol Vis Sci. 2016 Jul 1;57(9):OCT176-83. doi: 10.1167/iovs.15-18879.

MeSH Terms

Conditions

Corneal DiseasesMacular EdemaDiabetes Mellitus

Condition Hierarchy (Ancestors)

Eye DiseasesMacular DegenerationRetinal DegenerationRetinal DiseasesGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • Matthias Bolz, MD

    AKh Linz, Augenabteilung

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 12, 2015

First Posted

November 25, 2015

Study Start

December 1, 2014

Primary Completion

December 1, 2015

Study Completion

December 1, 2015

Last Updated

November 25, 2015

Record last verified: 2015-11

Locations